Latest News
Trowers & Hamlins' corporate team has advised the shareholders on the sale of cloud service provider Carrenza Limited to Six Degrees Technology Group Limited (6DG), for an undisclosed sum.
Carrenza was an early promoter of enterprise cloud computing, launching the Carrenza Cloud in 2006, and provides Infrastructure as a Service (IaaS) and Platform as a Service (PaaS) cloud services for hosting mission-critical applications and websites for public, private and third sector clients, including RBS, de Bijenkorf, Majestic Wine, WWF and Age UK. Carrenza also host OFFICIAL security certified G-Cloud services with a public sector client base which includes Government Digital
- 19/04/2016
Ogier has assisted Medicxi Ventures, formerly Index Ventures Life Sciences, with its formation as an independent life sciences firm. Medicxi Ventures comprises all of the existing life sciences portfolio companies, funds and team from Index Ventures.
The Ogier team also worked with Medicxi Ventures on the establishment of Medicxi Ventures I, a new fund focused on early-stage life sciences investments in Europe, which has raised 210 million euros with GlaxoSmithKline and Johnson & Johnson Innovation-JJDC Inc. The closing of Medicxi Ventures I consolidates the position of Medicxi Ventures as one of the largest life sciences focused venture firms in Europe.
- 19/04/2016
BMO Global Asset Management has released its latest white paper, titled "Finding a new balance with alternatives,” which considers the evolution of the traditional 60/40 equity/bond balanced portfolio split over the past several decades and concludes that, given the current market environment, investors should consider including alternative strategies to generate potentially stronger returns.
Alternative investments feature a diverse group of strategies and management styles. Among those often included within liquid alternatives mutual funds are equity hedge, credit, relative value and macro-driven tactics. Combined within a multi-manager fund, the overall objective typically emphasises absolute returns – relying less on the direction
- 19/04/2016
Quercus Assets Selection and Swiss Life Asset Managers have completed a deal to acquire Antin Solar Investments (ASI) in a 50:50 joint venture. ASI now operates as Azienda Solare Italiana Spa.
On 18 December 2015 the joint venture, called Quercus Swiss Life Italian Solar Srl, had entered into a binding agreement with Antin Infrastructure Partners to acquire a 100 per cent stake in ASI.
Founded in 2011, ASI has become a leading photovoltaic (PV) investment platform in Italy. The portfolio today consists of nine plants with a total installed capacity of 77.1 MW, and is the fifth largest operator in
- 19/04/2016
Speyside Private Fund Advisers, a special situations buyout firm, has held the closing of Speyside Equity Fund I, a USD130 million buyout fund that will focus on investment opportunities in specialty chemicals, industrials/metal forming & food ingredients businesses and continue the disciplined investment approach that Speyside has successfully executed for the past 10 years.
Investors in Speyside Equity Fund I LP include a blue chip roster of leading institutional limited partners such as, endowments, foundations, insurance companies, fund of funds, public and private pensions, and family offices. The Fund was closed in less than 4 months of fundraising and was
- 19/04/2016
GSO Capital Partners has appointed David Flannery as a Senior Managing Director focusing on distressed strategies in both private and public markets. He will be based in New York and brings to Blackstone his extensive experience across leveraged finance.
With nearly 25 years of industry experience, Flannery joins Blackstone from Anchorage Capital Group, where he focused on illiquid credit opportunities and CLOs. Prior to joining Anchorage, he worked at Bank of America Merrill Lynch (BAML) for five years where he held several global group head roles including Chief Risk Officer of Global Banking & Markets and Global Head of Leveraged
- 19/04/2016
Investcorp has agreed the sale of CSIdentity (CSID) to Experian (EXPN), a global information services company, for an enterprise value of approximately USD360 million. The transaction is subject to standard regulatory approvals.
Founded in 2006 and headquartered in Austin, Texas CSID is a market leading provider of enterprise level identity theft protection technology solutions to consumers, businesses, and government agencies. The Company’s solutions, provided on the basis of a recurring software-as-a-service (SaaS) business model, proactively detect credit and non-credit related identity theft, notify affected parties and help restore compromised identities.
Through its technology fund, Investcorp Technology Partners III, Investcorp initially
- 19/04/2016
- 19/04/2016
G-Therapeutics has secured up to EUR26 million in a Series A financing round from an investment syndicate consisting of Gimv, Wellington Partners, LSP and Inkef Capital alongside the company’s founders/management.
This investment will fund the company’s clinical trials up to CE mark (EU) and IDE (US) approval.
G-Therapeutics (http://gtherapeutics.com/#About) develops an implantable neuro stimulator for patients with incomplete spinal cord injury. The company’s device supports motor function recovery for better and faster rehabilitation by stimulating the spinal cord. The company was founded in 2014 as a spin-off of the Center for Neuro-Prosthetics of the renowned École Polytechnique Fédérale de Lausanne
- 19/04/2016
Fried, Frank, Harris, Shriver & Jacobson has appointed Dr Christian Kleeberg as a partner in the Mergers and Acquisitions and Private Equity Practice, resident in the Firm's Frankfurt office.
Dr Kleeberg focuses his practice on private mergers and acquisitions, predominantly for private equity and other financial investors. He also represents German and international strategic investors as bidders or sellers in auction processes, and has extensive experience advising clients on the purchase and restructuring of large companies in Germany.
"The addition of Christian is a crucial step in continuing to expand our European private equity offering," says David Greenwald, chairman of
- 19/04/2016
The Board of Electra Private Equity has appointed Neil Johnson as non-executive Chairman and Director of the Company with effect from 12 May 2016.
Following Johnson’s appointment, Dame Kate Barker, who has been Chairman of the Company since 5 November 2015, will resume her roles as Senior Independent Director and Chairman of the Remuneration and Nomination Committee. Roger Perkin will stand down from these roles, which he has held since Dame Kate was appointed as Chairman of the Company in November 2015.
Dame Kate Barker, Chairman, says: “This appointment follows a rigorous selection process and we are delighted to
- 19/04/2016
Special Reports
Featured
- Intel
- May 20, 2024
- Intel
- May 17, 2024
- Awards
- May 16, 2024
- Intel
- May 16, 2024
- Intel
- May 15, 2024
Events
05 June, 2024 – 8:30 am
12 September, 2024 – 8:30 am
12 September, 2024 – 6:00 pm
24 October, 2024 – 8:30 am
